Physician profile
Ariel D Soffer
NPI 1386682748
$13,505.58
in general payments reported to CMS, 2019-2025
38 companies · $5,955 in 2025
The $5,955 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $309 · 2021: $501 · 2022: $355 · 2023: $814 · 2024: $5,399 · 2025: $5,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $9,760 · Food and Beverage: $2,408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $9,760.00 |
| Food and Beverage | $2,407.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $9,776.10 | 2023-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Boston Scientific Corporation | $473.62 | 2020-2025 | General - Therapies, Watchman Flx, Varithena Administration Pack |
| Tactile Systems Technology INC | $394.08 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Amgen INC. | $383.54 | 2019-2025 | Repatha, Repatha, Otezla |
| Heartflow, INC. | $309.61 | 2023-2025 | Ffrct |
| Novo Nordisk INC | $267.89 | 2019-2025 | Ozempic, Wegovy |
| Lilly USA, LLC | $196.24 | 2022-2025 | Mounjaro, Zepbound |
| Cashflow Solutions, LLC | $166.14 | 2022-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Stryker Corporation | $133.43 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $122.74 | 2022-2023 | Venclose Maven Catheter |
| Glaxosmithkline, LLC. | $100.76 | 2023-2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $97.27 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $85.04 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $82.05 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $80.74 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $80.33 | 2021-2024 | Venaseal |
| Kowa Pharmaceuticals America, INC. | $67.83 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.19 | 2020-2025 | Airsupra |
| Biocompatibles, INC. | $63.61 | 2019 | |
| Cvrx, INC. | $61.31 | 2024-2025 | Barostim Neo System |
| Astellas Pharma US INC | $52.52 | 2024-2025 | Veozah |
| Esperion Therapeutics, INC. | $51.00 | 2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.20 | 2024-2025 | Jardiance, Synjardy |
| Pfizer INC. | $41.39 | 2024 | |
| Cleerly, INC. | $40.66 | 2023-2025 | Cleerly Labs, Cleerly Ischemia |
| Abbott Laboratories | $40.28 | 2021-2023 | Proclaim |
| Abbvie INC. | $30.71 | 2022 | |
| Becton, Dickinson and Company | $24.12 | 2024 | Venclose Maven Catheter |
| Amarin Pharma, INC. | $22.69 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.10 | 2022 | |
| Philips North America LLC | $20.12 | 2023 | |
| Vital Connect, INC | $20.05 | 2024 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $20.00 | 2020 | |
| Eisai INC. | $19.42 | 2025 | |
| Scpharmaceuticals INC. | $18.44 | 2023 | |
| Radius Health, INC. | $16.10 | 2019 | |
| Dexcom, INC. | $11.26 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Soffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.